Measure the recovery that matters
Hospital mobility, scans without symptoms, surgical timing and the difference between test performance and daily activity.
A discharge assessment can show that someone stands and walks better. A wrist sensor can record more movement. A scan can show joint degeneration. These are useful observations, but they answer different questions. Rehabilitation depends on connecting the measurement to the person's problem, the decision being made and the activity they hope to regain.
Today's reading moves from exercise during an acute hospital admission to scans in people without pain, the timing of cervical spinal cord surgery, adolescent sports recovery and cognitive rehabilitation. A stroke-monitoring study makes the distinction especially clear: clinical motor scores improved while the balance of movement between the two wrists did not change detectably.
All 88 registered sources and 15 study domains were inspected. Discovery returned 809 journal-article metadata records plus one book identifier. Compared with October 17, 49 article records entered and 47 left the capped results; those are retrieval changes, not publication dates or retractions. All 12 unavailable sources were retried without recovery. Eight research reports receive focused appraisal. Selected main methods, results or limitations were reviewed for the sacroiliac, cervical-myelopathy and stroke reports; the other five use primary abstracts or subscription previews. Licensed chapters, paid courses and recordings remain outside verified full-content coverage.
Protect physical function while treating the acute illness
A trial in an Acute Care for the Elderly unit randomized 47 adults aged 70 or older to usual care or a multicomponent exercise programme based on VIVIFRAIL. Participants averaged 83 years of age. The intervention combined resistance/power work, balance and gait exercises; the reported exposure was 4 ± 2 sessions during admission.
The primary outcome was the Short Physical Performance Battery (SPPB), a measure of lower-limb physical performance. At discharge, the between-group difference favored exercise by 3.18 points, 95% confidence interval 1.3–5.1. Sit-to-stand time also favored exercise by −11.3 seconds, 95% CI −20.6 to −1.9. These are encouraging short-term findings from a small trial.
The practical question is how to preserve the abilities a person needs after leaving hospital. This report supports attention to function during admission, with exercise selected and supervised according to clinical circumstances. It does not establish lasting independence, fewer readmissions or a safe unsupervised routine for every acutely ill person.
Clinical notes: discharge performance and longer-term recovery
Assessments occurred at admission and discharge. The abstract reports intention-to-treat analysis using generalized estimating equations. The MMSE, a secondary cognitive measure, also favored exercise by 2.16 points, 95% CI 0.6–3.7. That short-term score change is not proof of preventing dementia or delirium. Multiple secondary outcomes require cautious interpretation.
Full allocation methods, eligibility details, missing-data procedures, adverse-event tables and post-discharge follow-up were unavailable after publisher access attempts. The title's description of a low-cost programme is not an economic evaluation. A mean session count is not a universally tested prescription.
Date transparency: the journal's searchable official listing says October 17, while the paper's own PubMed journal-publication field says August 3 and has no electronic date. This edition preserves that conflict and does not use today's indexing to establish a first-publication date.
Primary hospital-exercise trial · Publisher listing and abstract · DOI: 10.1093/ageing/afag301
A degenerative scan finding needs a clinical explanation
A review of 17 studies involving 3,873 asymptomatic adults examined CT and MRI findings of sacroiliac joint degeneration. Importantly, the headline estimate for any degenerative feature came from six studies and 1,429 people, not the entire review population. Its pooled prevalence was 71.1%, 95% CI 25.8%–94.6%, with very high heterogeneity, I² 96%.
That wide interval and variation prevent treating 71.1% as a precise universal rate. Still, the basic observation matters: structural changes can be present without symptoms. A scan report containing “degeneration” does not, by itself, identify the source of a person's pain or determine which procedure would help.
The authors separated patient-level estimates from studies counting individual joints. They also found varied imaging methods, lesion definitions and reasons for scanning. Some participants had imaging for other medical problems while reporting no low-back pain; this was not one uniformly sampled healthy population.
Clinical notes: prevalence is not diagnostic accuracy
The review had no designated symptomatic comparator for its pooled prevalence question. It cannot supply the sensitivity, specificity or likelihood ratio needed to calculate whether a finding explains pain in a particular patient. Nor does a high background prevalence prove that every degenerative finding is irrelevant.
Fourteen included studies used CT and three used MRI. The protocol was not registered. Definitions sometimes used composite grades, and joint-level analyses could not account fully for the correlation between the two joints in one person. The main methods, principal patient/joint results, discussion and limitations were reviewed; complete supplementary extraction tables, image figures and underlying studies were not independently appraised.
For board study, keep the sequence clear: identify the structure, relate it to symptoms and examination, then evaluate whether a proposed intervention has evidence for that clinical problem. An image alone does not complete those steps.
Primary asymptomatic sacroiliac imaging review · Publisher main report
Duration matters, but the evidence does not set a universal deadline
A review examined 14 observational cohorts with 3,162 surgical patients who had degenerative cervical myelopathy, a disorder affecting the spinal cord in the neck. Outcomes were assessed at least twelve months after surgery. Longer symptom duration was associated with worse neurological recovery.
Across seven studies reporting adjusted analyses, the pooled odds ratio for a study-defined poor postoperative neurological outcome was 1.78, 95% CI 1.23–2.57. The outcome was derived from the modified Japanese Orthopaedic Association (mJOA) measure, but studies defined a poor result differently. This is not a 1.78-point change on the scale, nor an estimate per additional month of symptoms.
Six- and twelve-month duration cutoffs produced signals in subgroup analyses, but the test comparing cutoff subgroups was not significant (P = .89). Only the twelve-month signal persisted after excluding high-risk-of-bias studies. These results do not establish a safe waiting period or a single date by which every operation must occur.
Clinical notes: prognosis, confounding and thresholds
Searches were conducted November 16, 2025. All included studies were nonrandomized, most retrospective. Symptom onset was inconsistently defined: neck/arm symptoms and true myelopathic symptoms may have been counted differently. Patient recall, disease severity, referral pathways, surgical selection and different adjustment sets can influence the observed association.
The main methods explicitly converted estimates to odds of a poor outcome, with longer versus shorter duration defined by each study. Restriction to categorical duration excluded part of the available literature. Lack of a significant age or severity moderator does not prove those factors unimportant; meta-regression had limited power.
The authors support avoiding unnecessary delays once myelopathy is established, while acknowledging that disease trajectories differ. Their analysis does not compare surgery with nonsurgical care or replace individualized specialist assessment. Selected main methods, principal estimates, cutoff analyses and limitations were read; complete study tables, figure images, supplements and original cohorts were not audited.
Primary symptom-duration review · Publisher methods and discussion
Return to sport is more than the calendar
Researchers followed 160 adolescents aged 12–18 after a first traumatic lateral patellar dislocation managed without surgery and with standardized rehabilitation. They assessed strength, functional performance, apprehension and patient-reported function at three months. Delayed return meant failure to resume unrestricted preinjury-level sport within six months; 76 participants, 47.5%, met that definition.
Each 10-percentage-point decrease in quadriceps limb symmetry was associated with higher odds of delay: adjusted odds ratio 1.82, 95% CI 1.29–2.57. Persistent patellar apprehension had an aOR of 2.71, 95% CI 1.31–5.62. Each ten-point decrease on the instability-specific BPII 2.0 questionnaire had an aOR of 1.51, 95% CI 1.13–2.02.
The findings support evaluating several dimensions of recovery. They do not show that correcting one measure alone will cause earlier return, and they do not establish a stand-alone clearance rule for an individual athlete.
Clinical notes: odds, discrimination and validation
An odds ratio of 1.82 is not an 82-percentage-point increase in risk. The model's area under the ROC curve was 0.80, 95% CI 0.73–0.86. That describes discrimination between outcomes in the studied data; it is not 80% accuracy for every new athlete and does not establish calibration or external validity.
Strength symmetry is a ratio to the opposite limb, not a complete description of absolute strength or readiness. Full measurement methods, rehabilitation adherence, recurrence handling, missing data and model-validation procedures were unavailable. No numerical clearance threshold, surgical-selection rule or return date is inferred from the abstract.
Primary patellar-dislocation cohort · Publisher abstract and subscription boundary
A cognitive test gain still needs a daily-life outcome
A meta-analysis compared real with sham repetitive transcranial magnetic stimulation (rTMS) across neurological and psychiatric conditions. It extracted 748 cognitive measures from 137 studies involving 5,972 participants. A three-level model addressed the fact that multiple measures can come from one study.
The overall standardized effect on objective cognition was Hedges' g = 0.28, favoring real stimulation, with I² 37.3%. The abstract provides a P value below .0001 but no confidence interval for that pooled estimate. It reports follow-up across two to 52 weeks; this should not be read as proof that every condition or protocol produces a year-long benefit.
Only 6% of studies measured subjective cognition. The authors explicitly identify uncertainty about translation into meaningful subjective or functional improvement. A test-score effect is not a 28% recovery rate, a guarantee of independence or evidence that one protocol fits every diagnosis.
Clinical notes: moderators are not randomized dose comparisons
Searches covered trials through July 2025. The report explores stimulation site, frequency, session count and diagnosis. Associations across studies can be confounded by patient selection, co-interventions and study quality; a meta-regression relating more sessions to larger effects does not randomly assign those sessions.
The abstract's favorable subgroup and frequency estimates do not establish an optimal clinical prescription. Complete precision estimates, detailed bias assessments, multiplicity handling, harms, durability analyses and the proposed prediction tool's validation were unavailable. The tool itself was not tested in this edition, and no treatment parameters are recommended.
Primary cognitive-rTMS meta-analysis · DOI: 10.1016/j.brs.2026.103226
A moving wrist does not necessarily mean a purposeful hand
A Japanese pilot monitored both wrists during the first post-stroke week. Of 32 enrolled patients, 24 completed seven-day monitoring: 16 in a study-defined milder group and eight in a more severe group. Clinical arm-motor scores improved in both groups, while the relative balance of recorded activity between the affected and unaffected wrists did not change detectably over time.
On day one, the more severe group had lower affected-side activity: model coefficient −468,257 counts/day, 95% CI −826,564 to −109,949. These are device-derived activity counts, not a universal functional score or a target number of purposeful movements.
The sensors also recorded walking, sleep, transfers, therapy and passive movement during care. The investigators did not annotate those activities or quantify actual wear hours. The measurement therefore describes overall wrist acceleration in a hospital environment. It cannot tell whether someone successfully used the hand to eat, dress or manage an object.
Clinical notes: capacity, activity and selection
The activity ratio used log10(affected-wrist counts/unaffected-wrist counts). Zero represents equal recorded activity, not normal function. Study strata used an FMA-UE cutoff greater than 45 versus 45 or lower, borrowed from subacute-stroke work; it was not validated as an acute-phase severity rule.
Five patients left the analysis because of early discharge/transfer and three because of missing sensor data. Final analysis required complete seven-day files; characteristics of excluded patients were unavailable. Eligibility also limited severe cognitive or sensory impairment, and this was one small centre. Sex-adjusted repeated-measure models cannot remove all these selection and measurement limitations.
The study did not randomize therapy, standardize rehabilitation dose or analyze individual-level correspondence between changes in clinical scores and sensor measures. It supplies no causal evidence for a specific training protocol or neural mechanism. Main methods, participant flow, discussion and limitations were reviewed; detailed outcome tables, figure images and original device data were not independently audited.
Primary acute-stroke wrist-activity pilot · Actual main publisher text
Read the comparison before choosing the treatment
An eight-week low-back-pain trial with 45 participants compared treadmill walking with vertical traction/body-weight support, treadmill walking alone and core exercises; all received conventional physical therapy. The combined intervention improved some gait, disability and repositioning outcomes more than treadmill exercise alone. The abstract supplies no numerical between-group effects or confidence intervals, making clinical magnitude uncertain. It also cannot separate vertical unloading from harness support. Fifteen people per group and four-week follow-up limit inference about durability; the report does not establish routine traction benefit for all low-back pain. Primary treadmill/traction trial, October 16.
A methodological review examined 265 spine-surgery randomized trials with statistically significant primary outcomes. Among the 43 trials with binary outcomes, the median fragility index was four patients, and 76.7% of binary outcomes had an index of five or less. This asks how many hypothetical outcome changes would erase statistical significance under that calculation. It does not measure effect size, show that those outcomes actually changed, or prove the treatment ineffective. The selected significant-trial sample also cannot represent every spine trial. Full algorithms, extraction tables and the underlying trials were unavailable. Primary statistical-fragility review, October 17.
Keep the recovery pathway connected
Established guidance: NICE CG83 concerns rehabilitation after critical illness, a different population from the geriatric ward trial above. Its discharge recommendations include assessment of physical, sensory, communication, cognitive, psychological and social needs, with attention to daily activities and participation. It calls for arrangements for continuing rehabilitation before discharge and a functional reassessment at two to three months after critical-care discharge for people with rehabilitation needs. The actual recommendations were read; underlying evidence reviews were not appraised. This is existing guidance, not a new October 18 recommendation. Actual NICE critical-illness recommendations.
Earlier safety notice: FDA's device-update index lists the Infinion CX spinal-cord-stimulator lead recall under September 3. The actual notice concerns unused SC-2317-50 and SC-2317-70 lead kits: stop use/distribution, segregate and return affected stock. FDA says the action does not affect already implanted devices and recommends no added patient monitoring beyond routine follow-up. Mechanical stress at the anchor may cause high impedance or lead fracture. The manufacturer's customer letter was dated June 17. This is a rechecked earlier notice, not a new alert or a recommendation to remove every implanted stimulator. Product images, manufacturer attachments and device-database entries were not reviewed. Actual FDA Infinion CX notice.
Education reminder: AAPM&R's October journal club remains listed for October 19, 7:30–8:30 p.m. Central, with discussion of autonomic/endothelial dysfunction after spinal cord injury and an adverse-event review of knee platelet-rich-plasma injections. The course description says members are eligible and “No Credit Offered.” The listing was reread; linked papers and lectures were not appraised for clinical conclusions here. This edition records neither attendance nor CME credit. Official journal-club description.
Test the interpretation
A meta-analysis finds sacroiliac degenerative imaging features in many adults without symptoms, with wide confidence intervals and high heterogeneity. A patient with low-back pain has similar features on CT. Which interpretation best fits the review?
- The scan proves the sacroiliac joint is the pain source.
- The pooled prevalence gives the scan's sensitivity for diagnosing sacroiliac pain.
- Degenerative findings can never be clinically relevant.
- The finding needs clinical correlation; background prevalence alone neither identifies the pain source nor establishes treatment benefit.
Reveal answer and reasoning
D. A prevalence review in asymptomatic people describes how commonly findings occur without reported symptoms. It does not establish diagnostic accuracy in symptomatic patients or predict response to an intervention. The scan can contribute information, but interpretation still requires the clinical question, symptoms, examination and relevant treatment evidence.
Words worth keeping
- Physical performance
- What a person demonstrates during a specified task or test, such as standing or walking.
- Participation
- Involvement in life situations, including family roles, work, school and recreation.
- Prevalence
- The proportion of a defined population with a finding or condition.
- Incidental finding
- A finding that may be unrelated to the problem being investigated.
- Heterogeneity
- Variation between studies; a pooled average may describe individual settings poorly when variation is large.
- Odds ratio
- A comparison of odds between groups or exposure levels; it is not automatically a risk ratio or probability difference.
- Discrimination
- A prediction model's ability to rank people with different outcomes.
- Calibration
- How closely predicted probabilities match observed outcomes.
- Hedges' g
- A standardized difference between group averages, adjusted for small-sample bias.
- Myelopathy
- Clinical dysfunction involving the spinal cord.
- Accelerometry
- Measurement of acceleration; recorded movement does not necessarily reveal its purpose.
- Fragility index
- The number of hypothetical outcome changes needed to reverse statistical significance under a specified calculation.
References & the coverage record
- Preservation of functional capacity and lower-limb mechanical power during acute hospitalisation: effects of a low-cost multicomponent exercise programme in older adults-a randomised controlled trial. Age and ageing · PMID 42891965 · DOI 10.1093/ageing/afag301
- Imaging findings of sacroiliac joint degeneration are prevalent in asymptomatic adults: a systemic review and meta-analysis. Skeletal radiology · PMID 42891683 · DOI 10.1007/s00256-026-05386-x
- Symptom duration and postoperative outcomes in degenerative cervical myelopathy: a systematic review and meta-analysis. Neurosurgical review · PMID 42891726 · DOI 10.1007/s10143-026-04543-z
- Clinical and functional predictors of delayed return to sport after first-time patellar dislocation in adolescents: A prospective cohort study. Irish journal of medical science · PMID 42891790 · DOI 10.1007/s11845-026-04695-3
- Transdiagnostic Efficacy, Durability, and Optimal Parameters of rTMS for Cognitive Rehabilitation: A Comprehensive Meta-Analysis. Brain stimulation · PMID 42892417 · DOI 10.1016/j.brs.2026.103226
- Seven-day Accelerometer-derived Wrist Activity after Acute Stroke Stratified by Hemiparesis Severity: A Prospective Observational Pilot Study. Progress in rehabilitation medicine · PMID 42889237 · DOI 10.2490/prm.20260058
- Effects of treadmill exercise with and without vertical traction on gait, pain, disability, trunk proprioception, and depression in patients with chronic mechanical low back pain: A randomized controlled trial. Gait & posture · PMID 42892150 · DOI 10.1016/j.gaitpost.2026.110672
- Statistical fragility of significant outcomes in spine surgery randomized controlled trials: a systematic review of binary and continuous outcomes. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · PMID 42891820 · DOI 10.1007/s00586-026-10439-9
Eight research reports were appraised: a hospital exercise randomized trial, asymptomatic sacroiliac imaging prevalence review, cervical-myelopathy prognostic review, adolescent patellar-dislocation cohort, cognitive-rTMS meta-analysis, acute-stroke wrist-activity pilot, treadmill/traction randomized trial and spine-trial statistical-fragility review. Main sacroiliac methods, principal patient/joint results, discussion and limitations were read; the 71.1% composite came from six studies/1429 people within the full seventeen-study/3873-person review. Selected cervical main methods, principal results, threshold analyses and limitations were read; the adjusted OR is for longer versus shorter study-defined duration and a study-defined poor outcome, not points or a per-month effect. All cervical cohorts were observational, so no universal surgical deadline is inferred. Stroke main methods, participant flow, discussion and limitations plus the primary abstract were read: 24 complete cases from32 enrolled, seven-day selection, unlogged non-wear and unannotated movement prevent a purposeful-hand-use interpretation. Detailed extraction/outcome tables, image figures, supplements, source data and underlying studies were not independently audited. The other five reports use primary abstracts or subscription previews; the patellar and fragility publisher pages explicitly display subscription boundaries. Hospital DOI/direct/abstract access failed; its searchable official Oxford listing says October17, while its own PubMed publication field says August3 and contains no electronic date. Both are disclosed, without asserting a resolved first-publication date. DOI pages for traction, rTMS and the blindness/low-vision item were redirect stubs; actual ScienceDirect requests returned403. The blindness item has no PubMed abstract and inaccessible full text, so no programme details or outcomes are asserted from its title. All88 registered checks, all15 capped/truncated domain results,49 newly retrieved titles/dates and all38 portal comparisons were inspected. Twelve unavailable sources were retried with zero recovery. The single new portal link was a broccoli-seed food recall, not an appraised rehabilitation-guidance update. Dynamic page-hash changes do not verify chapter changes. Discovery contains809 article metadata records plus one own BookDocument identifier, not810 fully appraised publications. Fourteen focused-search titles/dates were screened; eleven selected records yielded ten primary abstracts and one absent abstract, all checked. Older October1/2 Frontiers reports, preclinical work, protocols and nonclinical search noise were distinguished from new clinical reports; fetched Frontiers full pages were not given full-content appraisal credit. FDA device/drug update lists were screened beyond registry landing pages. The actual earlier Infinion CX notice was read, with exact models, unused-stock scope, already-implanted-device distinction and routine-follow-up wording; manufacturer letters, images and linked device-database entries were not reviewed. Actual NICECG83 discharge/functional-reassessment recommendations were read as established critical-illness guidance, distinct from an ordinary geriatric ward trial and not a new guideline or underlying-evidence appraisal. AAPMR October19 journal-club description, time, member eligibility and no-credit label were reread; linked papers, lectures and recordings were not clinically appraised. Licensed textbooks, paid courses, podcasts, recordings and unindexed sources remain unavailable or unreviewed. No physician review, CME, official-board-item status or exhaustive worldwide source coverage is claimed.
The discovery window was 2026/09/18–2026/10/18. A journal index check can miss work not yet indexed. A retrieved landing page does not verify every linked publication, paid course, podcast or textbook chapter. Candidate counts are discovery records, not validated practice changes.
See every registered source and its status → · Download this edition’s machine-readable coverage record
Educational, not medical advice. Discuss treatment choices with your clinician. Sources and evidence evolve; each dated edition preserves what was checked for that issue.